Echocardiographic Findings in Infants of Diabetic Mothers and Its Relation to Maternal Glycemic Control

November 25, 2022 updated by: Marwa Mohamed Farag

The aim of this work was to:

  1. Evaluate the use of echocardiography in the assessment of hemodynamic stability in newborns.
  2. Determine the prevalence of congenital heart diseases or any cardiac abnormalities in infants born to diabetic mother in relation to the glycemic control of their mothers

Study Overview

Status

Completed

Study Type

Observational

Enrollment (Actual)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Alexandria, Egypt, 21131
        • Neonatal Intensive Care Unit (NICU) of Alexandria University Maternity Hospital.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 second to 1 week (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The study was conducted on 50 neonates admitted to the neonatal intensive care unit in Alexandria University Children's Hospital.

This study included two groups:

Group Ι: Include 25 neonates born to diabetic mother Group II: Include 25 neonates born to non-diabetic mothers as a control group (reference group).

Description

Inclusion Criteria:

  • Infant of diabetic mother (IDM) (pregestational and gestational diabetes) born in Alexandria University Children 's Hospital (AUCH) whatever their weight or their gestational age

Exclusion Criteria:

  • Neonates aged more 7 days.
  • Patient born outside the tertiary center of Alexandria University Children 's Hospital.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Neonates born to diabetic mothers
Neonates born to non-diabetic mothers (control)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Detection of incidence of congenital heart disease in infants of diabetic mothers
Time Frame: First week
This was done using echocardiography: two-dimensional study, color Doppler, pulsed and continuous wave Doppler as well as m-mode study.
First week
Hemodynamic significance of patent ductus arteriosus (PDA)and patent Foramen Ovale (PFO)
Time Frame: First two months of life
This was done using echocardiography: two-dimensional study, color Doppler, pulsed and continuous wave Doppler as well as m-mode study for assessments of PDA and PFO in infants of diabetic mothers in comparison with healthy controls.
First two months of life
Assessment of left ventricular dimensions in infants of diabetic mothers in comparison to healthy controls.
Time Frame: First two months of life

Using M-mode images under guidance of two dimensional echocardiography in parasternal long axis view was done for all participants measuring of the following:

  • Left ventricular end systolic diameter (LVDs).
  • Left ventricular end diastolic diameter (LVDd).
  • Inter ventricular septal diameter (IVSd).
  • Left ventricular posterior wall thickness during diastole (LVPWd).
  • Left ventricular posterior wall thickness during systole (LVPWs) those measures are compared in infant of diabetic mothers and healthy controls.
First two months of life
Assessment of left ventricular dimensions in infants of diabetic mothers in comparison to healthy controls.
Time Frame: First two months of life

Using M-mode images under guidance of two dimensional echocardiography in parasternal long axis view was done for all participants measuring of the following:

  • Ejection fraction (EF) .
  • Fractional shortening (FS). those measures are compared in infant of diabetic mothers and healthy controls.
First two months of life

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Asmaa MR Emara, MBBCh, Faculty of Medicine, Alexandria University, Egypt
  • Study Director: Iman M Marzouk, PhD, Faculty of Medicine, Alexandria University, Egypt
  • Study Director: Aly M Abdel-Mohsen, PhD, Faculty of Medicine, Alexandria University, Egypt

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 8, 2020

Primary Completion (Actual)

June 12, 2021

Study Completion (Actual)

June 20, 2021

Study Registration Dates

First Submitted

September 10, 2021

First Submitted That Met QC Criteria

September 10, 2021

First Posted (Actual)

September 20, 2021

Study Record Updates

Last Update Posted (Actual)

November 30, 2022

Last Update Submitted That Met QC Criteria

November 25, 2022

Last Verified

November 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 0106399

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infant of Diabetic Mother

Subscribe